Viz.ai and Cleerly Partner on Heart Disease Evaluation Using Artificial Intelligence
New partnership delivers critical insights to more cardiovascular care teams to identify and define atherosclerosis earlier
New partnership delivers critical insights to more cardiovascular care teams to identify and define atherosclerosis earlier
Steven Borg joins as CTO, David McGovern as Vice President of Marketing, and Jim Hartman advances to CCO to support company's mission to create a...
CREDENCE and PACIFIC-1 study data demonstrate potential power of AI-QCT ISCHEMIA
Company’s AI-enabled technology for future heart attack risk assessment accepted into FDA’s TAP Pilot and to be validated in landmark TRANSFORM trial
Learn more about Cleerly's AI-enabled technology that identifies the presence, type, and amount of heart disease which improves understanding of heart attack risk, and empowers clinicians to personalize treatment for better outcomes.
<div style="padding:56.25% 0 0 0; position:relative;"><iframe src="https://player.vimeo.com/video/708877726?h=61fd91e16c&badge=0&autopause=0&player_id=0&app_id=58479" frameborder="0" allow="autoplay; fullscreen; picture-in-picture" allowfullscreen style="position:absolute; top:0;left:0; width:100%; height:100%;" title="Cleerly / Beats"></iframe></div><script src="https://player.vimeo.com/api/player.js"></script>